DNA damage responses (DDR) to double-strand breaks (DSBs) alter cellular transcription programs at the genome-wide level. Through processes that are less well understood, DSBs also alter transcriptional responses locally, which may be important for efficient DSB repair. Here, we developed an approach to elucidate the cis-acting responses to DSBs in G 1 phase cells. We found that DSBs within a gene body silence its expression, as well as the transcription of local undamaged genes at a distance defined by the spread of ␥-H2AX from the DSB. Importantly, DSBs not only repress ongoing transcription but also block the inducible expression of regional genes. DSB-mediated transcriptional repression depends on DDR signaling but does not require the generation of inaccessible chromatin. Our findings demonstrate that in G 1 phase cells, DDR signaling establishes a robust and extensive region of transcriptional repression spreading from DSB sites and introduce an approach to study the mechanistic impact of targeted DNA breaks in nearly any chromatin environment.
the phosphatidylinositol 3-kinase-like protein kinase (PI3KK) family members ATM and DNA-PKcs. These kinases phosphorylate hundreds of downstream effector molecules that function in the canonical DDR (12) (13) (14) . A key target of ATM and DNA-PKcs is the histone variant H2AX, which is phosphorylated on serine 139, forming ␥-H2AX. This histone posttranslational modification can propagate from the break site, extending for megabases along chromatin to form ␥-H2AX domains (15) . The ␥-H2AX domains act as scaffolds for recruitment and retention of other nuclear factors involved in histone modification, chromatin remodeling, end processing, and repair (16, 17) . Thus, DSBs initiate a signaling cascade that drives substantial alterations in the genomic microenvironment, including the regional landscape of chromatin and nuclear factors. To this end, the downstream functional consequences of DSB signaling on local, regional, and global gene expression in G 0 /G 1 phase cells remain largely unexplored.
In cycling cells, DSBs at or near an active gene transiently repress its transcription via ATM-and DNA-PKcs-dependent mechanisms (18) (19) (20) (21) (22) . However, DSBs activate divergent signaling pathways, depending on the cell cycle phase in which they occur, leading to vastly different cellular responses. For example, DDR signaling activates distinct checkpoint and repair pathways in G 1 versus S versus G 2 phases, each of which recruits its own sets of factors to DSB-proximal chromatin (23, 24) . As such, the specific cell cycle phase in which a DSB occurs may differentially impact local chromatin reorganization, DSB end processing, and, likely, the transcription of genes near a lesion. With regard to the transcription of genes near a lesion, a persistence of transcription near a break site could cooperate or interfere with repair processes, especially given that NHEJ factors form complexes with RNA polymerase II (RNAPII) when DSBs occur in transcribed genes (25) . RNA-DNA hybrids also accumulate at endogenous DSBs in transcriptionally active regions, where they may influence NHEJ and HR (26, 27) . Conversely, RNA polymerase complexes and RNA-DNA hybrid structures at the DSB site could act as physical barriers to end processing and repair (28, 29) . Thus, controlling transcriptional activity in the vicinity of a DSB may be a critical component of the mechanisms that facilitate the rapid and precise resolution of the lesion (29, 30) .
We developed an approach to study DDR regulation of transcription at loci harboring a single, targeted DSB in G 0 /G 1 phase cells. We chose a cell system in which DSBs persist unrepaired, which generates a sustained DNA damage response and which allows us to detect changes that may otherwise be obscured by rapid repair. We found that DSBs targeted to sites either within or several kilobases outside of a gene body repress its ongoing transcription. Importantly, the same lesions also block induced expression of the proximal gene, indicating that ongoing transcription is not required for DSB-mediated repression. Remarkably, we found that transcriptional repression spreads to distal genes within the ␥-H2AX domain in a DDR-dependent manner. Together, our findings provide a rigorous demonstration that genomic DSBs incurred in G 0 /G 1 suppress regional gene expression and underscore the utility of our experimental model for a systematic dissection of the responses to DSBs within a range of chromatin environments.
RESULTS

Generation of persistent, targeted DSBs in G 1 phase cells.
To interrogate the local transcriptional response to DSBs, we developed an experimental system to generate high levels of persistent DSBs at predetermined sites in the genome of G 1 -synchronized cells ( Fig. 1A) . Specifically, we employed a v-Abl-transformed murine pre-B cell line (Abelson line) that can be arrested in G 1 phase by treatment with the Abl kinase inhibitor imatinib (STI571 or STI) (31) . We chose a cell line that was deficient for the core NHEJ factor, DNA ligase IV. Because NHEJ is the major DSB repair pathway utilized in noncycling cells, DSBs persist unrepaired in these Abelson lines when they are placed under G 1 arrest (32) .
To target DSBs at preselected genomic sites, a doxycycline-inducible Cas9 (pCW-Cas9) was stably integrated into Abelson cells deficient for DNA ligase IV (LigIV Ϫ/Ϫ :iCas9 cells). Treatment of cycling LigIV Ϫ/Ϫ :iCas9 cells with doxycycline induced robust Cas9 data indicate that DDR signaling is intact in these G 1 -arrested cells and is specific to regions targeted for a DSB.
Persistent DSBs in G 1 phase repress transcription of an active endogenous gene. We first set out to determine how persistent DSBs within an active endogenous gene affect its transcription. We chose to target the Irf4 locus, which is constitutively expressed in our cell line. G 1 -arrested, LigIV Ϫ/Ϫ :iCas9 cells were nucleofected with a gRNA targeting a site within Irf4 intron 6, about 6.3 kb downstream of the Irf4 promoter ( Fig. 2A ). As expected, we observed high levels of persistent DSBs at the target site at 24 h postnucleofection ( Fig. 2B) . A persistent break within the Irf4 gene body significantly reduced the levels of its corresponding mRNA, as measured by reverse transcription (RT)-quantitative PCR (qPCR) analysis at 24 h postnucleofection (Fig. 2C) . In contrast, expression of a control gene, Tnks2, located on a different chromosome, was unaffected ( Fig. 2C ). Analysis of nascent transcript levels yielded comparable results ( Fig. 2D ). Similar reductions in transcript levels were observed using primers for regions upstream (primer set P1) or downstream (primer set P2) of the DSB site. Because the break interrupts the transcriptional unit, the observed effects on transcription could be due to active repression, the instability of truncated transcripts, or both. To determine whether DSB repression of transcription requires the disruption of the gene body, we targeted Cas9 to a site 9.5 kb upstream of the Irf4 promoter ( Fig. 2A and E ). As observed for breaks within the gene body, a DSB upstream of the same transcriptional unit led to a nearly identical reduction in total and nascent transcripts ( Fig. 2F and G). We conclude that single DSBs in G 1 phase can silence expression of proximal genes, even when they do not directly interrupt the transcriptional unit.
DSBs block transcriptional activation of an inducible endogenous gene. To understand whether DSBs can regulate the induction of gene expression, we targeted Cas9 to the endogenous Ifit locus, which harbors a cluster of interferon-inducible genes. Importantly, regulation of these genes is restricted to the activities of their proximal promoters, which harbor multiple interferon-stimulated response elements (ISREs) that bind the STAT1/2 transcription factors (33, 34) . Indeed, expression of Ifit1 is rapidly induced in G 1 -arrested, LigIV Ϫ/Ϫ Abelson cells upon treatment with the type I interferon, interferon beta (IFN-␤) ( Fig. 3A ), without inducing a DNA damage response ( Fig.  3B ). Thus, the Ifit1 locus provides an excellent model to test if DSBs not only silence ongoing gene transcription but also block the activation of transcription at genes proximal to the lesion.
We targeted Cas9 to two sites at the Ifit1 locus, one 3 kb downstream of Ifit1 (gIfit1 3=) and one within the Ifit1 gene body (gIfit1 intron) ( Fig. 3C to E). The former DSB lies ϳ12 kb 3= of the Ifit1 promoter, while the latter is in the single Ifit1 intron, ϳ6.6 kb 3= to the promoter ( Fig. 3C ). To test whether each DSB affected ongoing transcription, we induced Ifit1 expression 2 h prior to nucleofection with gRNAs ( Fig. 3F ). We then assessed nascent transcript levels at 24 h postnucleofection using primer sets upstream (primer set P1) and downstream (primer set P3) of the intronic break site, as well as spliced Ifit1 transcripts (primer set P2) ( Fig. 3C ). As expected, nascent mRNA levels were reduced when a DSB was introduced into the Ifit1 intron, which disrupts the transcriptional unit ( Fig. 3G ). Importantly, repression also was observed upon introduction of the gIfit1 3= DSB downstream of the transcriptional unit and its polyadenylation site ( Fig. 3H ). As a control for general effects on the interferon response, we found that transcript levels for Isg15, an IFN-␤-induced gene on chromosome 4, were unaltered ( Fig. 3G and H). Consistent with our data for Irf4, we conclude that a DSB either within or outside the Ifit1 gene represses its ongoing transcriptional activity.
Notably, the Ifit1 locus also allowed us to gauge the impact of a DSB on induced transcription rather than simply ongoing gene expression. For this purpose, we treated the G 1 -arrested cells with IFN-␤ at 24 h after nucleofection, the time point of maximal DSB accumulation ( Fig. 3D , E, and I). Analysis of the induced mRNA levels after 4 h of IFN-␤ treatment revealed a DSB-dependent reduction in Ifit1 transcripts, regardless of whether the DSB was targeted within or downstream of the Ifit1 gene body ( Fig. 3J and K). Thus, establishment of repression at an endogenous DSB site is not dependent on preexisting transcriptional activity. Importantly, our data also demonstrate that DSBs in G 1 phase cells both repress ongoing transcription and block induced expression of a neighboring gene, even in the presence of a potent activating signal.
One recent study implicated the c-Abl kinase in facilitating transcription at DSB sites (35) . To ensure that c-Abl inhibition by imatinib is not the sole underlying mechanism for transcriptional repression in response to DSBs at an adjacent gene, we arrested LigIV Ϫ/Ϫ :iCas9 cells in G 1 using the CDK4/6 inhibitor palbociclib, which spares c-Abl activity (59) . Both gene body and downstream breaks blocked Ifit1 induction in palbociclib-treated cells, indicating that DSB-dependent repression of local gene transcription is independent of Abl kinase inhibition via imatinib ( Fig. 3L and M) . Chromatin accessibility near persistent DSBs. A potential mechanism by which DSBs mediate transcriptional repression could be a break-induced loss of chromatin accessibility at nearby regulatory elements. In this regard, prior studies generally have concluded that DSBs enhance accessibility at DNA ends but lead to compaction of flanking chromatin (18, (36) (37) (38) . However, the impact of a single DSB on chromatin accessibility at proximal regulatory elements remains unknown. The well-defined regulatory architecture of Ifit1 afforded an ideal opportunity to test DSB-accessibility relationships.
For this purpose, we examined chromatin accessibility following the introduction of targeted Ifit1 DSBs via the assay for transposase-accessible chromatin using sequencing (ATAC-seq). Cells harboring the Ifit1 intronic break and treated with IFN-␤, as outlined in Fig. 3I , exhibited enhanced accessibility for ϳ500 bp on either side of the DSB site ( Fig. 4A) . Notably, the Ifit1 promoter remained accessible, despite potent transcriptional repression ( Fig. 4A ). Statistical comparison of global ATAC-seq data for control cells versus those for cells harboring an Ifit1 intronic DSB revealed no significant changes in chromatin accessibility genome-wide, with the exception of the break site itself (Fig. 4B ). We conclude that global chromatin accessibility remains remarkably stable in the presence of a DSB and that the break-induced block in Ifit1 transcription is not driven by occlusion of its promoter.
DSB-dependent transcriptional repression extends to distal genes within the ␥-H2AX domain. Previous studies have suggested that DSB-dependent transcriptional repression is limited to genes that are either directly damaged by a break or situated within a few kilobases of the lesion (18, 20, 21, 39, 40) . Since DDR-signaling platforms in chromatin extend hundreds of kilobases from a break site, we hypothesized that transcriptional silencing might spread further in G 1 cells, perhaps throughout the ␥-H2AX domain. The efficiency of DSB formation in v-Abl-transformed cells, coupled with unique features of the Ifit locus, namely, the proximity of several interferoninducible genes, permits us to test more rigorously whether repression spreads beyond a directly adjacent gene.
Initially, we measured IFN-␤-induced transcription of neighboring genes Ifit3b, Ifit3, and Ifit2 (Fig. 5A ) in cells harboring an intragenic Ifit1 break. DSB-mediated repression extended to all of the inducible Ifit genes in this region, albeit to a lesser extent than Ifit1 itself ( Fig. 5B ). Similarly, a DSB introduced into a second Ifit gene, Ifit2, blocked activation of the other IFN-␤-inducible genes in this cluster (Fig. 5C ). We conclude that regional repression is independent of the precise DSB location.
We next sought to determine if repression extended to more distal genes within the ␥-H2AX domain in response to a DSB. The intronic break in Ifit1 produced a ␥-H2AX 
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Molecular and Cellular Biology domain that spread for several hundred kilobases on each side, as monitored by chromatin immunoprecipitation-DNA sequencing (ChIP-seq) (Fig. 5D ). Two constitutively expressed genes, Stambpl1 and Kif20b, are located near each end of the region decorated by ␥-H2AX. Remarkably, we observed a significant reduction in the transcript levels of Kif20b (ϳ40%), which is located ϳ275 kb away from the Ifit1 DSB (Fig. 5E ). The transcription of Stambpl1, whose promoter lies ϳ455 kb away from the Ifit1 DSB, also was affected significantly, albeit to a lesser extent (ϳ20%) (Fig. 5E ). In contrast, the expression of two genes positioned on either side of the ␥-H2AX domain, Atad and Tnks2, remained unchanged (Fig. 5F ). Indeed, whole-transcriptome analysis of control versus Ifit1 DSB samples revealed a significant DSB-dependent decrease in the expression of genes lying within the Ifit1 ␥-H2AX domain compared to all other genes (Fig. 5G ). Furthermore, breaks at Ifit2 elicited similar levels of Stambpl1 and Kif20b repression (Fig. 5H) . Thus, we conclude that DSB-induced transcriptional repression in an endogenous locus can spread for several hundred kilobases on either side of a break site throughout the ␥-H2AX domain. DSB-induced local gene silencing depends on the DNA damage response and reduced RNAPII activity. To determine whether the spread of gene repression from a DSB site requires DDR signaling, which generates ␥-H2AX, we treated cells with Fig. 3I . The arrow denotes the gIfit1 intron target site. (B) Plot depicting the log 2 fold change of the read counts for each ATAC-seq peak and the mean of the normalized read counts for each peak between cells nucleofected with gEmpty and cells nucleofected with the gIfit1 intron and treated with IFN-␤, as outlined in Fig. 3I (results are averages from three biological replicates [n ϭ 3]). Each dot represents an individual ATAC-seq peak. Two peaks (indicated in red) are called significantly different by the DESeq2 program (Wald test, P Ͻ 0.05) and correspond to the peaks on either side of the Ifit1 intronic DSB, as visualized in panel A. combined ATM (KU55933) and DNA-PKcs (NU7026) inhibitors (DDR inhibitor 1 [DDRi-1] treatment) or the dimethyl sulfoxide (DMSO) vehicle immediately after gRNA nucleofection. The DDRi-1 treatment did not restore induced Ifit1 mRNA levels in cells with Ifit1 intronic DSBs, possibly because intragenic breaks lead to transcript instability (Fig. 6A ). Consistent with this possibility, when a DSB was targeted outside of the Ifit1 gene body (Ifit1 3= DSB), The DDRi-1 treatment partially rescued its transcriptional activation (Fig.  6A) . Notably, silencing of the IFN-␤-inducible gene Ifit3b and of the constitutive gene Kif20b also was reversed by DDR inhibition (Fig. 6A) . To further confirm that silencing is dependent on DDR signaling, we employed a second set of ATM (KU60019) and DNA-PKcs (NU7441) inhibitors (the DDRi-2 treatment), which led to a similar rescue of transcription at neighboring genes (Fig. 6B) . Thus, DDR-dependent repression can spread for a significant distance from a DSB to suppress not only ongoing but also induced gene transcription in the resultant ␥-H2AX domain.
Prior studies indicated that the levels of elongating or total RNA polymerase II (RNAPII) are reduced at genes adjacent to DSBs (18, 20, 21). However, it remains unclear how RNAPII activity is affected at loci near persistent DSBs in G 1 phase cells. We thus measured the levels of elongating, C-terminal domain Ser2-phosphorylated (CTD S2P) RNAPII via chromatin immunoprecipitation (ChIP) in response to Ifit1 downstream DSBs, as outlined in Fig. 3I . We chose to focus on DSBs outside the gene body, as they do not present a physical barrier to RNAPII progression. Because previous reports indicated that RNAPII levels at Ifit1 were maximal at 2 h subsequent to interferon treatment, we assessed RNAPII CTD S2P occupancy at that time point (41) . Indeed, we observed an ϳ20% reduction in transcript levels and a corresponding decrease in elongating RNAPII levels over the Ifit1 gene compared to the levels in undamaged cells (Fig. 6C to E) . As expected, the levels were unchanged at the Isg15 control locus (Fig. 6D and E) . Thus, we conclude that transcriptional repression of DSB-adjacent endogenous genes in G 1 phase occurs through a loss of RNAPII activity, corroborating previous findings in cycling cells at transcriptional reporter loci (18) .
DISCUSSION
A major hurdle for understanding the functional consequences of DDR signaling in noncycling cells has been a lack of approaches to target DSBs at predetermined sites in native chromatin. Recently developed cellular systems have used endonucleases that cleave at a specific recognition sequence. However, the DSBs are limited to a small collection of naturally occurring sites that may not be ideal for studying certain aspects of the damage response. For example, AsiSI and I-PpoI cleave predominantly in promoter regions or ribosomal DNA repeats, respectively (20, 21, 39, 40) . We established an experimental system that leverages the flexibility of the CRISPR/Cas9 technology to generate DSBs in NHEJ-deficient cells arrested in G 1 phase. Our approach was used to create site-specific DSBs with a high efficiency (50 to 90% broken alleles) at multiple, predetermined genomic sites, enabling us to interrogate transcriptional responses to persistent DSBs. By targeting breaks to multiple sites in the Ifit1 locus, where transcription is regulated solely by promoter elements, we provide definitive evidence that DSBs can repress endogenous gene transcription in G 1 phase cells independently of damage to the gene body itself or its key regulatory elements.
These advances build on prior investigations of DSB-induced silencing, many of which employed systems that simultaneously generate multiple DSBs within gene bodies or near genes with ongoing transcriptional activity. Thus, although DSB-mediated repression of a proximal gene was observed in most cases, it remained unclear whether preexisting transcriptional activity at or near a break site was required for this functional outcome. Indeed, the RNA polymerase II-associated factors ENL and NELF-E have been implicated in DSB-induced repression in cycling cells; however, their recruitment to DSBs was dependent on active transcription near the break site (22, 42) . Leveraging the inducible nature of Ifit genes, we show that DSBs not only repress ongoing gene expression but also block induced transcription, even when the lesion resides outside the transcriptional unit. This reduction of the induced Ifit1 transcript in response to adjacent DSBs corresponds with the decreased levels of active RNAPII at Ifit1. Although the precise mechanisms of DSB-mediated gene repression remain an important unresolved question, they likely are independent of changes in chromatin accessibility at key regulatory elements, as revealed by our comparisons of ATAC-seq data for cells harboring intact or broken Ifit alleles.
An important finding to emerge from our approach is that DSB-mediated repression is not limited to a neighboring gene. Prior studies had suggested that transcriptional silencing is restricted to DSB-harboring or -proximal genes, without having a significant impact on other genes within a ␥-H2AX domain (20, 21, 39, 40) . In addition, the architectural complex cohesin was implicated in the protection of more distal ␥-H2AX domain genes from DSB-mediated repression (43) . We found that although transcriptional silencing required DDR signaling, repression could extend to significant distances from a DSB, even past CTCF-cohesin binding sites, ultimately attenuating expression of both inducible and constitutive genes throughout the resultant ␥-H2AX domain. Although we cannot rule out the possibility that repression of the Ifit genes results from disruption of a transcriptional coregulatory mechanism within this locus and not the DSB per se, the observed repression of the distal genes Kif20b and Stambpl1 suggests bona fide DSB-dependent long-range gene silencing. Curiously, topoisomerase II (TOP2) localizes to chromatin loop anchors, where it relieves torsional strain through the formation of transient, TOP2-linked DNA breaks (44, 45) . DSB intermediates in TOP2 cleavage complexes (TOP2ccs) are thought to be shielded from the DNA surveillance machinery and do not elicit a DDR (2) . Perhaps this cloaking mechanism prevents the regional transcriptional repression that may be necessary for the efficient and accurate repair of genotoxic DSBs but not these transient, TOP2-associated breaks.
While it is unclear if ␥-H2AX itself is essential for this mode of transcriptional repression, the histone modification serves as a proxy that highlights the reaches of DDR signaling. Intriguingly, ATM recruitment may be restricted to only a short stretch of chromatin near endogenous DSB sites, suggesting that DDR signaling spreads through megabasesize domains via contacts between the break and more distal sites, rather than through direct linear propagation (46) . Moreover, DSBs appear to boost cis interactions within ␥-H2AX domains, as revealed using a chromosome conformation capture-based technique (capture-HiC) (47) . In agreement with the results of these studies, we observed a nonuniform distribution of ␥-H2AX from our Ifit1 DSB. This finding, together with our transcriptional data, raises the compelling possibility that DSBs enhance the contacts of surrounding chromatin with ATM loaded near the damaged site to spread DDR signaling and impose transcriptional silencing at more distal genes. As transcriptionally active regions are prone to DSBs, it is conceivable that active repression of genes is important for minimizing the appearance of additional DSBs within a confined region, thus limiting the risk of genomic rearrangements. Our approach, which generates targeted endogenous DSBs and a sustained DDR signaling response, should provide a means to rigorously test such hypotheses in the future. Indeed, the inherent flexibility of this system should lead to a deeper understanding of factors that facilitate the spread of DDR signaling to distal sites, as well as its full impact on regional transcription, chromatin landscapes, and repair.
MATERIALS AND METHODS
Cell culture. LigIV Ϫ/Ϫ v-Abl-transformed pre-B cells were described previously (31, 32) . pCW-Cas9 (catalog number 50661; Addgene) was used to generate LigIV Ϫ/Ϫ v-Abl-transformed pre-B cell lines with a stably integrated, doxycycline-inducible Cas9 (LigIV Ϫ/Ϫ :iCas9 cells). For Cas9 induction, LigIV Ϫ/Ϫ :iCas9 cells were treated with 6 g/ml doxycycline (Sigma) for 12 h prior to G 1 arrest using imatinib (3 M, Plasmids. To generate the pKLV-U6gRNA(BbsI)-UbcThy1.1 gRNA expression vector, pKLV-U6gRNA(BbsI)-PGKpuro2ABFP (catalog number 50946; Addgene) was digested with BamHI and NotI to remove the PGKpuro2ABFP cassette and replace it with a Ubc-Thy1.1 cassette. The BbsI site in the Ubc promoter sequence was destroyed via site-directed mutagenesis. gRNA sequences were cloned into the BbsI gRNA cloning site as previously described (48) .
gRNA design. All gRNA sequences were designed using the MIT CRISPR design tool, with the exception of gEb, which was previously published (49, 50) . The gRNA sequences and oligonucleotide sequences used for cloning into pKLV-U6gRNA(BbsI)-UbcThy1.1 vector are listed in Table 1 . GAAAGCCAGCCAATGAATGC CACCGAAAGCCAGCCAATGAATGCGT TAAAACGCATTCATTGGCTGGCTTTC  6  gIrf4 intron  GGCCAACCCTACACCCTAAA  CACCGGCCAACCCTACACCCTAAAGT  TAAAACTTTAGGGTGTAGGGTTGGCC  13  gIrf4 5=  AGGCTAGGTTACGACTAGAA  CACCGGGCTAGGTTACGACTAGAAGT  TAAAACTTCTAGTCGTAACCTAGCCC  13  gIfit1 intron  ATGGCCAGAAATGGACACCG CACCGTGGCCAGAAATGGACACCGGT TAAAACCGGTGTCCATTTCTGGCCAC  19  gIfit1 3=  CTGTTCTGCTACCTGCCGAG  CACCGTGTTCTGCTACCTGCCGAGGT  TAAAACCTCGGCAGGTAGCAGAACAC 19  gIfit2  CAGACTTCCAGGAGTCGCAT  CACCGAGACTTCCAGGAGTCGCATGT  TAAAACATGCGACTCCTGGAAGTCTC  19 Nucleofection. LigIV Ϫ/Ϫ :iCas9 cells were treated with doxycycline for 36 h and imatinib for 24 h prior to nucleofection. For each nucleofection, 20 ϫ 10 6 cells were spun down and resuspended in 100 l Nucleofector solution for human B cells (Lonza) or Chica buffer 1SM (51) . Nucleofections were performed using an Amaxa Nucleofector II device (Lonza), program X-001, according to the manufacturer's instructions. Nucleofected cells were transferred directly to preequilibrated recovery medium containing doxycycline and imatinib at 10 ϫ 10 6 cells/ml and incubated for 24 h prior to harvesting for RNA and genomic DNA. For induced Ifit expression experiments, cells were treated with IFN-␤ for 4 h prior to harvest. IFN-␤ was added to the cell cultures at 2 h before nucleofection and to the recovery medium for ongoing transcription experiments with DSBs at the Ifit1 locus. For DDR inhibitor experiments, cells were transferred directly to recovery medium containing ATM and DNA-PKcs inhibitors or DMSO.
Southern blotting. Southern blotting of Cas9 DSBs was performed as previously described (50) . Briefly, genomic DNA was isolated from 5 ϫ 10 6 cells at the time points indicated above and in the figures, and 10 g of gDNA was used for digestion with the restriction enzyme. The restriction digestion enzymes and oligonucleotides used for amplification of the probes from genomic DNA for each Southern blotting/DSB site are listed in Table 2 .
Intracellular staining. Intracellular staining was performed using a BD Cytofix/Cytoperm fixation/ permeabilization solution kit (Thermo Fisher) according to the manufacturer's instructions. The primary antibody used was anti-FLAG M2 (catalog number F1804; Sigma).
Flow cytometric analysis. Flow cytometric analyses were performed using a BD FACSCalibur flow cytometer (BD Biosciences), and the data were analyzed using FlowJo software (FlowJo, LLC). The antibodies used were phycoerythrin-conjugated anti-rat CD90/mouse CD90.1 (catalog number 205903; BioLegend) and Alexa Fluor 647-conjugated goat anti-mouse IgG (catalog number A-21235; Invitrogen).
Immunoblot analysis. Whole-cell lysates were prepared using LDS sample buffer (Invitrogen). Standard immunoblotting techniques were used, as previously described (32) . The primary antibodies used were anti-␥-H2AX (catalog number 05-636; Millipore) and anti-GAPDH (anti-glyceraldehyde-3phosphate dehydrogenase; catalog number sc-365062; Santa Cruz).
Total RNA isolation, cDNA synthesis, and RT-qPCR analysis. Total RNA was isolated from 5 ϫ 10 6 to 10 ϫ 10 6 cells with the TRIzol reagent and DNase treated in solution for 10 min (Qiagen RNase-free DNase set) to remove any remaining genomic DNA. DNase-treated RNA was then purified using Qiagen RNeasy columns. Purified RNA was quantified using a NanoDrop 2000 spectrophotometer, and cDNA was synthesized from 1 g of RNA with random hexamers using SuperScript III reverse transcriptase (Thermo Fisher). Gene expression was assessed by qPCR using the Sybr green reagent (Sigma) and a Bio-Rad CFX Connect real-time PCR detection system. A ␤-2-microglobulin transcript was used as a normalization control for gene expression. The primers used for RT-qPCR analyses are listed in Table 3 . 
